As part of the TapImmune succession planning process, the Board undertook a comprehensive, global search for a top tier executive with experience across multiple functional areas of the biopharmaceutical industry. The worldwide search was conducted by Gayle Mattson, principal of Mattson and Company, New York, aboutique firm specializing in CEO and Board Searches.
"Vectrus was pleased with the work that Mattson and Company did on this project. We chose them because of their reputation, as well as their record of performance. They quickly became an integral part of our succession planning process, and provided the Board with strategic expertise, and counsel that enabled us to select a candidate that we have high confidence in," stated Lou Giuliano, Vectrus' Non-Executive Chairman.